Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:activeIngredient |
live attenuated varicella-zoster virus
|
| gptkbp:approvalYear |
1995
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J07BK01
|
| gptkbp:broadcastOn |
two doses
|
| gptkbp:contraindication |
pregnancy
immunocompromised individuals |
| gptkbp:indication |
adults
children |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
fever
injection site reaction rash |
| gptkbp:storage |
refrigerated
|
| gptkbp:treatment |
gptkb:chickenpox
|
| gptkbp:usedFor |
prevention of varicella
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:varicella-zoster_virus
gptkb:MRK |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Varivax
|